Diabetic eye disease epidemiology

Diabetic eye disease epidemiology
Leigh Spielberg
Leigh Spielberg
Published: Sunday, September 23, 2018
“THE 24.7 per cent prevalence of reported diabetic eye disease (DED) in Europe is much lower than the global burden of 34.6 per cent, but we will continue to see an increase in cases in Europe, and future healthcare planning needs to take this into consideration,” said Robert Finger, Bonn University Eye Hospital, Germany. Dr Finger presented his epidemiologic data of diabetic eye disease to delegates at the ESCRS/EURETINA Symposium: The Diabetic Eye, on Saturday afternoon. The data were based on an analysis of 38 studies that examined a total of more than 200,000 people with mostly type 2 diabetes. “Of all European nations studied, the lowest prevalence of DED was seen in France and Germany, with a significantly lower prevalence of proliferative diabetic retinopathy in France, he said. “There was no significant difference between northern and southern Europe.” And although DED risk factors and management differ between EU countries, all will experience an increase in cases. “By 2050, the number of persons with DED is expected to rise by 34 per cent to 8.6 million people in the EU,” said Dr Finger. “Of these, around one-third will require close monitoring and/or treatment due to advanced disease stages.” Fortunately, with improved screening and care, the prevalence of so-called diabetic blindness has decreased significantly as compared to 30 years ago, and the current European prevalence of diabetic blindness is nearly zero.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...